Hydrocortison Stada (Hydrocortisone)

Hydrocortison Stada is commonly employed for short‑term relief of mild to moderate inflammatory skin conditions, where reduction of redness, itching, and swelling is desired.

• Eczema (atopic dermatitis) flare‑ups, especially on arms, legs, or face
• Contact dermatitis caused by irritants or allergens, such as chemicals or plants
• Limited‑area psoriasis plaques where a mild corticosteroid is appropriate
• Seborrheic dermatitis affecting the scalp, eyebrows, or nasolabial folds
• Insect bite reactions with localized swelling, redness, and itching
• Minor skin irritations such as rash, sunburn, or mild allergic reactions

• Hydrocortison Stada delivers hydrocortisone to the skin, where it penetrates epidermal cells and binds to intracellular glucocorticoid receptors. The receptor‑ligand complex translocates to the nucleus and modulates gene transcription, suppressing pro‑inflammatory cytokines such as interleukin‑1, interleukin‑6, and tumor necrosis factor‑α. This down‑regulation reduces the synthesis of prostaglandins and leukotrienes, leading to decreased inflammation, edema, and immune cell activation at the site of application.

Topical hydrocortisone may cause local skin reactions, most of which are mild and reversible.

Common

• Mild burning or stinging sensation at the application site, usually lasting a few minutes
• Slight itching or dryness of the treated skin that improves with continued use or moisturization
• Minor redness or irritation that typically resolves within a few days without intervention

Serious

• Skin thinning (atrophy) with prolonged or excessive use, which may appear as increased translucency or fragility
• Development of stretch marks (striae) on treated areas, especially where the skin is thin or under tension
• Secondary bacterial, fungal, or viral infection of the skin due to local immunosuppression
• Allergic contact dermatitis presenting as a spreading rash, swelling, and possible blister formation

When using Hydrocortison Stada, certain precautions help minimize risks and ensure safe application.

• Avoid applying to broken, infected, or ulcerated skin unless directed by a healthcare professional.
• Do not use on large surface areas or for longer than recommended without medical supervision.
• Limit use on the face, groin, or armpits, as these areas are more prone to skin thinning.
• Keep the product away from eyes, mouth, and mucous membranes; wash hands after application.
• Discontinue use and seek medical advice if signs of an allergic reaction, worsening rash, or systemic effects appear.

Hydrocortison Stada can interact with other topical or systemic agents, influencing its efficacy or safety profile.

Avoid

• Concurrent use with other potent topical corticosteroids on the same area, which may increase risk of skin atrophy.
• Application over skin treated with occlusive dressings that enhance absorption and systemic exposure.
• Use together with topical calcineurin inhibitors on compromised skin without physician guidance.

Use with caution

• Systemic corticosteroids or immunosuppressants, as combined effects may suppress immune response further.
• Antifungal or antibacterial creams applied to the same site, which may alter drug absorption.
• Phototherapy or UV light treatments, which can increase skin sensitivity when combined with corticosteroids.